On January the 20th 2005, Prof. Sir Alasdair Breckenridge submitted oral evidence taken before the Health Commitee.I would bring to your attention Question 778 and Prof. Sir Alasdair Breckenridge's subsequent response:
Question 778: Response:
Professor Sir Alasdair Breckenridge:
"setting up communications, and this is absolutely critical for an agency like ours..... The second one is the issue of increased transparency and I have already mentioned the example of SSRIs. The other thing which we have done is that as of the middle of this year, when we give a licence, we will be issuing what we call a 'United Kingdom product public assessment report' which will give data of all the clinical trials on which we made our decision, so the public will be able to see again the evidence on which a drug has been licensed."
January 2005 ladies and gentlemen.
Sir Alisdair Breckinridge is Chairman of the MHRA and former member of the scientific committee of GSK (then known as SmithKline Beecham from 1992 to 1997)
GSK manufacture Seroxat - It does not take Albert Einstien to figure out what is going on here
The MHRA website still contains no information about Seroxat under The United Kingdom product public assessment report.
I have wrote to the MHRA and asked a series of questions under the terms of the Freedom of Information act.
I will keep you all posted should the MHRA respond within the next 20 days
Bob
"It's not about what they tell you, it's about what they don't."
~ Bob Fiddaman, Author, Blogger, Researcher, Recipient of two Human Rights awards
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Subscribe to:
Post Comments (Atom)
Please contact me if you would like a guest post considered for publication on my blog.
No comments: